The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pelvic Inflammatory Disease

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pelvic Inflammatory Disease


Psychiatry related information on Pelvic Inflammatory Disease

  • The incidence of pelvic inflammatory disease (PID) was low in LNG-IUD users regardless of age, whereas in the Nova T group, the PID rate was increased among the youngest women, which makes the difference between the devices significant (P < 0.01) [6].

High impact information on Pelvic Inflammatory Disease


Chemical compound and disease context of Pelvic Inflammatory Disease


Biological context of Pelvic Inflammatory Disease


Anatomical context of Pelvic Inflammatory Disease


Gene context of Pelvic Inflammatory Disease


Analytical, diagnostic and therapeutic context of Pelvic Inflammatory Disease


  1. Risk of pelvic inflammatory disease among intrauterine-device users irrespective of previous pregnancy. Osser, S., Gullberg, B., Liedholm, P., Sjöberg, N.O. Lancet (1980) [Pubmed]
  2. Peritoneal fluid and plasma levels of human macrophage colony-stimulating factor in relation to peritoneal fluid macrophage content. Weinberg, J.B., Haney, A.F., Xu, F.J., Ramakrishnan, S. Blood (1991) [Pubmed]
  3. Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. Wagar, E.A., Schachter, J., Bavoil, P., Stephens, R.S. J. Infect. Dis. (1990) [Pubmed]
  4. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. Lammel, C.J., Sweet, R.L., Rice, P.A., Knapp, J.S., Schoolnik, G.K., Heilbron, D.C., Brooks, G.F. J. Infect. Dis. (1985) [Pubmed]
  5. Analysis of the antigen specificity of the human serum immunoglobulin G immune response to complicated gonococcal infection. Hook, E.W., Olsen, D.A., Buchanan, T.M. Infect. Immun. (1984) [Pubmed]
  6. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Andersson, K., Odlind, V., Rybo, G. Contraception. (1994) [Pubmed]
  7. Evaluation of tetracycline or penicillin and ampicillin for treatment of acute pelvic inflammatory disease. Cunningham, F.G., Hauth, J.C., Strong, J.D., Herbert, W.N., Gilstrap, L.C., Wilson, R.H., Kappus, S.S. N. Engl. J. Med. (1977) [Pubmed]
  8. Cost-effectiveness of combined treatment for endocervical gonorrhea. Considering co-infection with Chlamydia trachomatis. Washington, A.E., Browner, W.S., Korenbrot, C.C. JAMA (1987) [Pubmed]
  9. Treatment of pelvic inflammatory disease: use doxycycline with an appropriate beta-lactam while we wait for better data. Wølner-Hanssen, P., Eschenbach, D., Paavonen, J., Holmes, K.K. JAMA (1986) [Pubmed]
  10. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Wasserheit, J.N., Bell, T.A., Kiviat, N.B., Wølner-Hanssen, P., Zabriskie, V., Kirby, B.D., Prince, E.C., Holmes, K.K., Stamm, W.E., Eschenbach, D.A. Ann. Intern. Med. (1986) [Pubmed]
  11. Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. Crombleholme, W.R., Schachter, J., Ohm-Smith, M., Luft, J., Whidden, R., Sweet, R.L. Am. J. Med. (1989) [Pubmed]
  12. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease. Hemsell, D.L., Heard, M.C., Hemsell, P.G., Nobles, B.J. Drugs (1988) [Pubmed]
  13. A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease. Gunning, J. Drugs (1986) [Pubmed]
  14. Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. Crombleholme, W., Landers, D., Ohm-Smith, M., Robbie, M.O., Hadley, W.K., DeKay, V., Dahrouge, D., Sweet, R.L. Drugs (1986) [Pubmed]
  15. A randomised controlled trial of prophylaxis of post-abortal infection: ceftriaxone versus placebo. Henriques, C.U., Wilken-Jensen, C., Thorsen, P., Møller, B.R. British journal of obstetrics and gynaecology. (1994) [Pubmed]
  16. Pediatric emergency medicine physicians' compliance with Centers for Disease Control and Prevention's guidelines for treatment of pelvic inflammatory disease. Segal, G.S. Archives of pediatrics & adolescent medicine. (1999) [Pubmed]
  17. Effects of cefotetan disodium, cefoxitin, cefazolin, and cefotaxime in vitro on polymorphonuclear leukocytes from patients with leukopenia and severe pelvic inflammatory disease. Ford, L.C., Nilsson, J.D., Hammill, H.A. Am. J. Obstet. Gynecol. (1988) [Pubmed]
  18. Salpingitis isthmica nodosa in female infertility and tubal diseases. Skibsted, L., Sperling, L., Hansen, U., Hertz, J. Hum. Reprod. (1991) [Pubmed]
  19. Current perspectives on oral contraceptive use. Burkman, R.T., Collins, J.A., Shulman, L.P., Williams, J.K. Am. J. Obstet. Gynecol. (2001) [Pubmed]
  20. Diagnostic delay after dimenhydrinate use in vomiting children. Anquist, K.W., Panchanathan, S., Rowe, P.C., Peterson, R.G., Sirnick, A. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. (1991) [Pubmed]
  21. Host defenses in acute pelvic inflammatory disease. I. Bacterial clearance in the murine uterus and oviduct. Chow, A.W., Carlson, C., Sorrell, T.C. Am. J. Obstet. Gynecol. (1980) [Pubmed]
  22. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Wiesenfeld, H.C., Hillier, S.L., Krohn, M.A., Amortegui, A.J., Heine, R.P., Landers, D.V., Sweet, R.L. Obstetrics and gynecology. (2002) [Pubmed]
  23. Peritoneal fluid leukotriene B4 and prostaglandin E2 in acute salpingitis. Heinonen, P.K., Aine, R., Seppälä, E. Gynecol. Obstet. Invest. (1990) [Pubmed]
  24. Serum CA 125 in acute pelvic inflammatory disease. Paavonen, J., Miettinen, A., Heinonen, P.K., Aaran, R.K., Teisala, K., Aine, R., Punnonen, R., Laine, S., Kallioniemi, O.P., Lehtinen, M. British journal of obstetrics and gynaecology. (1989) [Pubmed]
  25. Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Millman, K., Black, C.M., Stamm, W.E., Jones, R.B., Hook, E.W., Martin, D.H., Bolan, G., Tavaré, S., Dean, D. Microbes Infect. (2006) [Pubmed]
  26. Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. Kasper, D.L., Rice, P.A., McCormick, W.M. J. Infect. Dis. (1977) [Pubmed]
  27. Concentrations of tumor-associated trypsin inhibitor and C-reactive protein in serum in acute pelvic inflammatory disease. Paavonen, J., Lehtinen, M., Lehto, M., Laine, S., Aine, R., Räsänen, L., Stenman, U.H. Clin. Chem. (1989) [Pubmed]
  28. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. Peeling, R.W., Kimani, J., Plummer, F., Maclean, I., Cheang, M., Bwayo, J., Brunham, R.C. J. Infect. Dis. (1997) [Pubmed]
  29. Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients. Arredondo, J.L., Diaz, V., Gaitan, H., Maradiegue, E., Oyarzún, E., Paz, R., Reynal, J.L., Stamm, W., Zambrano, D. Clin. Infect. Dis. (1997) [Pubmed]
  30. Type of intrauterine device and the risk of pelvic inflammatory disease. Lee, N.C., Rubin, G.L., Ory, H.W., Burkman, R.T. Obstetrics and gynecology. (1983) [Pubmed]
  31. Comparative evaluation of clindamycin versus clindamycin plus tobramycin in the treatment of acute pelvic inflammatory disease. Gall, S.A., Constantine, L. Obstetrics and gynecology. (1990) [Pubmed]
  32. Prevention of acute pelvic inflammatory disease after hysterosalpingography: efficacy of doxycycline prophylaxis. Pittaway, D.E., Winfield, A.C., Maxson, W., Daniell, J., Herbert, C., Wentz, A.C. Am. J. Obstet. Gynecol. (1983) [Pubmed]
  33. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Ness, R.B., Trautmann, G., Richter, H.E., Randall, H., Peipert, J.F., Nelson, D.B., Schubeck, D., McNeeley, S.G., Trout, W., Bass, D.C., Soper, D.E. Obstetrics and gynecology. (2005) [Pubmed]
WikiGenes - Universities